Diabetes research services PRODO LABORATORIES, INC. specializes in providing high quality human and animal islets to support diabetes research, presenting a clear opportunity to position complementary research materials, outsourcing, and collaboration services to related biotech and academia customers exploring islet biology and diabetes therapeutics.

SMB biotechnology focus With 11-50 employees, PRODO is a small to mid-sized biotech service provider. This suggests potential willingness to engage in flexible partnerships, pilot programs, and scalable service arrangements with CROs, academic labs, and niche biotech firms seeking specialized islet resources.

Tech-enabled operations Existing tech stack including Salesforce, WordPress, Google Cloud, and Microsoft 365 indicates a modern, customer-centric operations model. This opens opportunities to propose CRM-integrated sales workflows, data management solutions, and digital collaboration tools to streamline partnerships.

Revenue range Current revenue is in the $1M-$10M band, signaling growth potential and openness to deal structuring such as strategic partnerships, volume-based pricing, and multi-year service contracts with larger pharma, accelerators, or research institutions seeking reliable islet supply.

Competitive positioning Operating in a space with well-known players (Lonza, Thermo Fisher, Charles River), PRODO can be approached as a specialized supplier for niche islet materials. Emphasize customization, speed-to-supply, and collaboration on bespoke research programs to win engagements against larger CROs.